Table 4.
Description | No. of Samples Tested | No. of Positive Controls Tested | No. of Negative Controls Tested | Total |
---|---|---|---|---|
Phase 1: Inclusivity panel testing | 64 | 16 | 48 | 128 |
Phase 2: Clinical panel testing | 324 | 20 | 44 | 388 |
Phase 3: Informational panel testing | 8 | 4 | 4 | 16 |
Total | 396 | 40 | 96 | 532 |